另据此前公开消息，香港公开发售阶段健康之路获34.42倍认购，公开发售的发售股份最终数目为330万股股份，占发售股份总数的约13.2%（任何超额配股权获行使前）。合共接获4,889份有效申请，受理申请数目3,225份，申购一手获配发H股份占所申请总数的概率约百分比为50%。According to Futu News on December 30th, $HEALTHYWAY INC (02587.HK)$ It opened higher on the first day, rising 27.56%. As of the press report of HK$9.95, the turnover was HK$11.9178 million, and the total market capitalization was HK$8.733 billion.
Market source: Futu Securities
According to previous information, in Futu's dark market trading on the previous trading day, Health Path opened high, closing up 23.72%, to HK$9.65, with a turnover of HK$4.788 million; 500 shares per lot, without handling fees, earned HK$925 per lot.
Also, according to previous public information, Health Path was subscribed 34.42 times during the Hong Kong public offering. The final number of shares offered for public sale was 3.3 million shares, accounting for about 13.2% of the total number of shares offered (before any over-allotment rights were exercised). A total of 4,889 valid applications were received, and the number of applications received was 3,225. The probability that the purchase of first-hand H shares was approximately 50% of the total number of applications.
Furthermore, during the international placement phase, Health Path was subscribed 0.98 times. The final number of shares offered internationally was 22.5 million shares, which is equivalent to 86.8% of the total number of shares offered (before any over-allotment rights are exercised). Futu Information collates relevant data in the following table:
Company Overview
Health Path operates a digital health care service platform in China. According to Frost & Sullivan, the company is the fourth largest digital healthcare service platform based on the number of registered individual users on the platform as of December 31, 2023. According to Frost & Sullivan, based on 2023 revenue, the company is also the fifth largest digital healthcare service platform, with a market share of less than 5%. Since 2001, the company has been providing healthcare services on digital platforms for individual users in China. In 2015, the company also began providing corporate services and digital marketing services to enterprises and organizations. Over the past 20 years, the company has been participating in the major digital transformation of China's health and healthcare industry to promote the company's business development.
The company's healthcare services enable it to establish strong and extensive links between the supply and demand sides of the digital health and wellness market. The large user base of the company's health care services encourages more doctors to practice and join the company's platform, expanding the company's network of doctors all over the country. This in turn has improved the quality of the company's medical consulting services and brought more business opportunities to the company's pharmaceutical sales business.
Financial Overview
In terms of financial overview, according to the prospectus, Health Path's revenue in 2021, 2022, and 2023 was approximately 0.431 billion yuan, 0.569 billion yuan, and 1.244 billion yuan respectively, with a review annual growth rate of 69.86%. In 2021, 2022, and 2023, the company recorded gross profit of about 0.173 billion yuan, 0.246 billion yuan, and 0.398 billion yuan respectively, with a review annual growth rate of 51.51%.
Click here for details >>Beginner's Guide: How to Draw New Shares? 5 days to keep in mind
Futu draws new shares, real 0 interest*｜0 handling fee^, undermarket trading is one step faster.Come and experience it >>
Edit/Joe
